NCT04498793 2020-09-03Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast CancerCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2 Unknown55 enrolled